Skip to main content
. 2011 Dec 20;20(3):679–686. doi: 10.1038/mt.2011.269

Figure 4.

Figure 4

Survival comparison of patients achieving positive ELISPOT response at month 4 (blue) versus those not achieving positive ELISPOT response at month 4 (red). Survival comparison of patients achieving and not achieving positive ELISPOT response from (a) time of procurement and (b) time of first vaccination (n = 18). ELISPOT, enzyme-linked immunospot.